Page last updated: 2024-09-04

olmesartan and sacubitril

olmesartan has been researched along with sacubitril in 3 studies

Compound Research Comparison

Studies (olmesartan)	Trials (olmesartan)	Recent Studies (post-2010) (olmesartan)	Studies (sacubitril)	Trials (sacubitril)	Recent Studies (post-2010) (sacubitril)
841	185	554	347	38	339

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	3 (100.00)	2.80

Authors

Authors	Studies
Gotou, H; Kario, K; Rakugi, H; Sasajima, T; Yamaguchi, M; Zhang, J	1
Almarjan, AI; Almarjan, SA; Masoud, AT	1
Eguchi, S; Iekushi, K; Kario, K; Morita, Y; Rakugi, H; Yarimizu, D	1

Reviews

1 review(s) available for olmesartan and sacubitril

Article	Year
Different Doses of Sacubitril/Valsartan Compared with Olmesartan in Patients with Essential Hypertension: A Systematic Review and Meta-Analysis. High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension, 2023, Volume: 30, Issue:3 Topics: Aminobutyrates; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Blood Pressure; Drug Combinations; Essential Hypertension; Humans; Hypertension; Tetrazoles; Valsartan	2023

Article

Year

Different Doses of Sacubitril/Valsartan Compared with Olmesartan in Patients with Essential Hypertension: A Systematic Review and Meta-Analysis.

High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension, 2023, Volume: 30, Issue:3

Topics: Aminobutyrates; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Blood Pressure; Drug Combinations; Essential Hypertension; Humans; Hypertension; Tetrazoles; Valsartan

2023

Trials

2 trial(s) available for olmesartan and sacubitril

Article	Year
Efficacy of sacubitril/valsartan versus olmesartan in Japanese patients with essential hypertension: a randomized, double-blind, multicenter study. Hypertension research : official journal of the Japanese Society of Hypertension, 2022, Volume: 45, Issue:5 Topics: Aminobutyrates; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Double-Blind Method; Essential Hypertension; Humans; Hypertension; Imidazoles; Japan; Tetrazoles; Treatment Outcome; Valsartan	2022
Twenty-Four-Hour Blood Pressure-Lowering Efficacy of Sacubitril/Valsartan Versus Olmesartan in Japanese Patients With Essential Hypertension Based on Nocturnal Blood Pressure Dipping Status: A Post Hoc Analysis of Data From a Randomized, Double-Blind Mult Journal of the American Heart Association, 2023, 04-18, Volume: 12, Issue:8 Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; East Asian People; Essential Hypertension; Humans; Hypertension; Tetrazoles; Valsartan	2023

Article

Year

Efficacy of sacubitril/valsartan versus olmesartan in Japanese patients with essential hypertension: a randomized, double-blind, multicenter study.

Hypertension research : official journal of the Japanese Society of Hypertension, 2022, Volume: 45, Issue:5

Topics: Aminobutyrates; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Double-Blind Method; Essential Hypertension; Humans; Hypertension; Imidazoles; Japan; Tetrazoles; Treatment Outcome; Valsartan

2022

Twenty-Four-Hour Blood Pressure-Lowering Efficacy of Sacubitril/Valsartan Versus Olmesartan in Japanese Patients With Essential Hypertension Based on Nocturnal Blood Pressure Dipping Status: A Post Hoc Analysis of Data From a Randomized, Double-Blind Mult

Journal of the American Heart Association, 2023, 04-18, Volume: 12, Issue:8

Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; East Asian People; Essential Hypertension; Humans; Hypertension; Tetrazoles; Valsartan

2023